Overview
Background
Doctor Anthony Verderosa is a Postdoctoral Researcher at the Institute for Molecular Bioscience (IMB) at the University of Queensland (UQ). Verderosa is the head researcher of a team dedicated to the design, synthesis, and microbiological evaluation of antibiotic conjugates. Their project involves synthetically linking different antibiotics and/or antibiotic adjuvants to generate novel dual-acting antimicrobial conjugates to treat resistant bacterial infections. Verderosa is an early career researcher (ECR) with expertise in synthetic organic chemistry, molecular bacteriology, antimicrobial testing, drug development, and biofilm remediation. His PhD (2020) involved transdisciplinary work (chemistry/microbiology) that focused on discovering and developing nitroxide-functionalised antibiotics - new drugs for treating and eradicating microbial biofilms. After submitting his PhD, Verderosa accepted a Postdoctoral Research position in molecular bacteriology and bacterial pathogenesis, where he developed new methods and strategies for tackling antimicrobial resistance.
Availability
- Dr Anthony Verderosa is:
- Available for supervision
Qualifications
- Doctor of Philosophy, Queensland University of Technology
Works
Search Professor Anthony Verderosa’s works on UQ eSpace
2023
Journal Article
Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial
Gavin, Nicole C., Wignall, Elizabeth, Marsh, Nicole, Marquart, Louise, Dobeli, Karen L., O'Brien, Catherine, Verderosa, Anthony D., Totsika, Makrina and Keogh, Samantha (2023). Perforated intravenous catheter design is acceptable for the administration of contrast-enhanced computed tomography administration in cancer patients: results of a pilot randomised controlled trial. The Journal of Vascular Access, 25 (5) 11297298231171422, 1519-1527. doi: 10.1177/11297298231171422
2023
Journal Article
Siderophore conjugates to combat antibiotic-resistant bacteria
Rayner, Beth, Verderosa, Anthony D., Ferro, Vito and Blaskovich, Mark A. T. (2023). Siderophore conjugates to combat antibiotic-resistant bacteria. RSC Medicinal Chemistry, 14 (5), 800-822. doi: 10.1039/d2md00465h
2023
Journal Article
Metals to combat antimicrobial resistance
Frei, Angelo, Verderosa, Anthony D., Elliott, Alysha G., Zuegg, Johannes and Blaskovich, Mark A. T. (2023). Metals to combat antimicrobial resistance. Nature Reviews Chemistry, 7 (3), 1-23. doi: 10.1038/s41570-023-00463-4
2023
Journal Article
A buried water network modulates the activity of the Escherichia coli disulphide catalyst DsbA
Wang, Geqing, Qin, Jilong, Verderosa, Anthony D., Hor, Lilian, Santos-Martin, Carlos, Paxman, Jason J., Martin, Jennifer L., Totsika, Makrina and Heras, Begoña (2023). A buried water network modulates the activity of the Escherichia coli disulphide catalyst DsbA. Antioxidants, 12 (2) 380, 380. doi: 10.3390/antiox12020380
2023
Journal Article
Use of antiviral agents and other therapies for COVID-19
Blaskovich, Mark A. T. and Verderosa, Anthony D. (2023). Use of antiviral agents and other therapies for COVID-19. Seminars in Respiratory and Critical Care Medicine, 44 (1), 118-129. doi: 10.1055/s-0042-1758837
2023
Journal Article
Repeat-unit elongations to produce bacterial complex long polysaccharide chains, an O-antigen perspective
Hong, Yaoqin, Hu, Dalong, Verderosa, Anthony D., Qin, Jilong, Totsika, Makrina and Reeves, Peter R. (2023). Repeat-unit elongations to produce bacterial complex long polysaccharide chains, an O-antigen perspective. EcoSal Plus, 11 (1), 1-16. doi: 10.1128/ecosalplus.esp-0020-2022
2022
Journal Article
Loss of β-ketoacyl acyl carrier protein synthase III activity restores multidrug-resistant escherichia coli sensitivity to previously ineffective antibiotics
Hong, Yaoqin, Qin, Jilong, Verderosa, Anthony D., Hawas, Sophia, Zhang, Bing, Blaskovich, Mark A. T., Cronan, John E. and Totsika, Makrina (2022). Loss of β-ketoacyl acyl carrier protein synthase III activity restores multidrug-resistant escherichia coli sensitivity to previously ineffective antibiotics. mSphere, 7 (3), e0011722. doi: 10.1128/msphere.00117-22
2022
Journal Article
Combination therapies for biofilm inhibition and eradication: a comparative review of laboratory and preclinical studies
Hawas, Sophia, Verderosa, Anthony D. and Totsika, Makrina (2022). Combination therapies for biofilm inhibition and eradication: a comparative review of laboratory and preclinical studies. Frontiers in Cellular and Infection Microbiology, 12 850030. doi: 10.3389/fcimb.2022.850030
2022
Journal Article
Isothiazolone-nitroxide hybrids with activity against antibiotic-resistant Staphylococcus aureus biofilms
Verderosa, Anthony D., Hawas, Sophia, Harris, Jessica, Totsika, Makrina and Fairfull-Smith, Kathryn E. (2022). Isothiazolone-nitroxide hybrids with activity against antibiotic-resistant Staphylococcus aureus biofilms. ACS Omega, 7 (6), 5300-5310. doi: 10.1021/acsomega.1c06433
2021
Journal Article
Thermoresponsive polymer-antibiotic conjugates based on gradient copolymers of 2-oxazoline and 2-oxazine
Park, Jong-Ryul, Verderosa, Anthony D., Totsika, Makrina, Hoogenboom, Richard and Dargaville, Tim R. (2021). Thermoresponsive polymer-antibiotic conjugates based on gradient copolymers of 2-oxazoline and 2-oxazine. Biomacromolecules, 22 (12), 5185-5194. doi: 10.1021/acs.biomac.1c01133
2021
Journal Article
Salmonella enterica BcfH Is a Trimeric Thioredoxin-Like Bifunctional Enzyme with Both Thiol Oxidase and Disulfide Isomerase Activities
Subedi, Pramod, Paxman, Jason J., Wang, Geqing, Hor, Lilian, Hong, Yaoqin, Verderosa, Anthony D., Whitten, Andrew E., Panjikar, Santosh, Santos-Martin, Carlos F., Martin, Jennifer L., Totsika, Makrina and Heras, Begoña (2021). Salmonella enterica BcfH Is a Trimeric Thioredoxin-Like Bifunctional Enzyme with Both Thiol Oxidase and Disulfide Isomerase Activities. Antioxidants and Redox Signaling, 35 (1), 21-39. doi: 10.1089/ars.2020.8218
2021
Journal Article
Antivirulence DsbA inhibitors attenuate Salmonella enterica serovar Typhimurium fitness without detectable resistance
Dhouib, Rabeb, Vagenas, Dimitrios, Hong, Yaoqin, Verderosa, Anthony D., Martin, Jennifer L., Heras, Begoña and Totsika, Makrina (2021). Antivirulence DsbA inhibitors attenuate Salmonella enterica serovar Typhimurium fitness without detectable resistance. FASEB BioAdvances, 3 (4), 231-242. doi: 10.1096/fba.2020-00100
2021
Journal Article
A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics
Verderosa, Anthony D., Dhouib, Rabeb, Hong, Yaoqin, Anderson, Taylah K., Heras, Begona and Totsika, Makrina (2021). A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. Scientific Reports, 11 (1) 1569. doi: 10.1038/s41598-021-81007-y
2020
Journal Article
An in vitro reconstructed human skin equivalent model to study the role of skin integration around percutaneous devices against bacterial infection
Bolle, Eleonore C. L., Verderosa, Anthony D., Dhouib, Rabeb, Parker, Tony J., Fraser, John F., Dargaville, Tim R. and Totsika, Makrina (2020). An in vitro reconstructed human skin equivalent model to study the role of skin integration around percutaneous devices against bacterial infection. Frontiers in Microbiology, 11 670. doi: 10.3389/fmicb.2020.00670
2020
Journal Article
Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms
Verderosa, Anthony D., Dhouib, Rabeb, Fairfull-Smith, Kathryn E. and Totsika, Makrina (2020). Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms. Antimicrobial Agents and Chemotherapy, 64 (1) e01685-19. doi: 10.1128/aac.01685-19
2019
Journal Article
Bacterial biofilm eradication agents: a current review
Verderosa, Anthony D., Totsika, Makrina and Fairfull-Smith, Kathryn E. (2019). Bacterial biofilm eradication agents: a current review. Frontiers in Chemistry, 7 824. doi: 10.3389/fchem.2019.00824
2019
Journal Article
Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin-dinitroxide conjugate
Verderosa, Anthony D., Harris, Jessica, Dhouib, Rabeb, Totsika, Makrina and Fairfull-Smith, Kathryn E. (2019). Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin-dinitroxide conjugate. MedChemComm, 10 (5), 699-711. doi: 10.1039/c9md00062c
2019
Journal Article
Profluorescent fluoroquinolone- nitroxides for investigating antibiotic-bacterial interactions
Verderosa, Anthony D., Dhouib, Rabeb, Fairfull-Smith, Kathryn E. and Totsika, Makrina (2019). Profluorescent fluoroquinolone- nitroxides for investigating antibiotic-bacterial interactions. Antibiotics, 8 (1) 19, 19. doi: 10.3390/antibiotics8010019
2019
Journal Article
Moraxella catarrhalis NucM is an entry nuclease involved in extracellular DNA and RNA degradation, cell competence and biofilm scaffolding
Tan, Aimee, Li, Wing-Sze, Verderosa, Anthony D., Blakeway, Luke V., D. Mubaiwa, Tsitsi, Totsika, Makrina and Seib, Kate L. (2019). Moraxella catarrhalis NucM is an entry nuclease involved in extracellular DNA and RNA degradation, cell competence and biofilm scaffolding. Scientific Reports, 9 (1) 2579. doi: 10.1038/s41598-019-39374-0
2017
Journal Article
Ciprofloxacin-nitroxide hybrids with potential for biofilm control
Verderosa, Anthony D., de la Fuente-Núñez, César, Mansour, Sarah C., Cao, Jicong, Lu, Timothy K., Hancock, Robert E.W. and Fairfull-Smith, Kathryn E. (2017). Ciprofloxacin-nitroxide hybrids with potential for biofilm control. European Journal of Medicinal Chemistry, 138, 590-601. doi: 10.1016/j.ejmech.2017.06.058
Funding
Current funding
Supervision
Availability
- Dr Anthony Verderosa is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Targeting the Biogenesis of Resistance Enzymes to Combat Antimicrobial Resistance
Principal Advisor
Other advisors: Professor Ulrike Kappler, Professor Mark Blaskovich, Professor Ian Henderson
-
Doctor Philosophy
Disrupting Bacterial Proteostasis through ClpP Activation
Associate Advisor
Other advisors: Professor Mark Blaskovich
-
Doctor Philosophy
Genetic basis for antimicrobial action and resistance
Associate Advisor
Other advisors: Professor Ian Henderson
-
Doctor Philosophy
Antibiotic Conjugates: Joining Together to Fight Antimicrobial Resistance
Associate Advisor
Other advisors: Professor Vito Ferro, Professor Mark Blaskovich
-
Doctor Philosophy
Investigations of the interactions between fluorescent antibiotics and bacteria
Associate Advisor
Other advisors: Dr Sanjaya Kc, Professor Mark Blaskovich
-
Doctor Philosophy
Clicking Conjugates into Place for the Fight Against Antibiotic Resistance
Associate Advisor
Other advisors: Professor Joanne Blanchfield, Professor Mark Blaskovich
Media
Enquiries
For media enquiries about Dr Anthony Verderosa's areas of expertise, story ideas and help finding experts, contact our Media team: